Status not kept up to date
Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy
NCT05001763 · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Updated 12 Aug 2021
- What is being tested
- Prucalopride; Placebo
- For
- Postoperative Ileus; Bladder Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years to 80 years. About 160 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 1 Sept 2021, ends 1 Oct 2023. Registered 12 Aug 2021.
- Results
- None posted yet.
In the researchers' words
The first purpose is to determine whether prucalopride can promote the recovery of intestinal function after robot-assisted laparoscopic radical cystectomy and urinary diversion. The secondary objectives is to speed up postoperative ventilation, defecation, reduce the time of first solid food tolerance, reduce postoperative hospital stay, reduce the incidence of readmission due to intestinal obstruction and the incidence of complications within 180 days.